{
  "created_at": "Thu Aug 05 1:10:51 +0000 2021",
  "id_str": "1423018425052499975",
  "full_text": "FDA officials, under pressure to swiftly grant full approval to the Pfizer Covid-19 vaccine, are in an intense debate over whether the agency will make the decision this month or stretch the timetable into early or mid-September https://t.co/VIzext6Aaz",
  "display_text_range": [
    0,
    252
  ],
  "entities": {
    "hashtags": [],
    "symbols": [],
    "user_mentions": [],
    "urls": [
      {
        "url": "https://t.co/VIzext6Aaz",
        "expanded_url": "https://on.wsj.com/3ftsC2o",
        "display_url": "on.wsj.com/3ftsC2o",
        "indices": [
          229,
          252
        ]
      }
    ]
  },
  "user": {
    "name": "The Wall Street Journal",
    "screen_name": "WSJ",
    "profile_image_url_https": "https://pbs.twimg.com/profile_images/971415515754266624/zCX0q9d5_normal.jpg"
  },
  "retweet_count": 49,
  "favorite_count": 64,
  "possibly_sensitive": false,
  "original_created_at": "Wed Aug 04 20:30:05 +0000 2021",
  "localize": [
    {
      "locale": "ja",
      "full_text": "FDA当局は、ファイザー社のCovid-19ワクチンの完全承認を早急に行う必要性に迫られており、今月中に決定するのか、それとも9月初旬または中旬までスケジュールを延ばすのかについて、激しい議論を展開している。https://t.co/VIzext6Aaz"
    },
    {
      "locale": "zh",
      "full_text": "美国食品和药物管理局官员在迅速批准辉瑞公司Covid-19疫苗的压力下，就该机构是在本月作出决定还是将时间表延长到9月初或9月中旬展开激烈辩论https://t.co/VIzext6Aaz。"
    },
    {
      "locale": "zh-Hant",
      "full_text": "美國食品和藥物管理局官員在迅速批准輝瑞公司Covid-19疫苗的壓力下，就該機構是在本月作出決定還是將時間表延長到9月初或9月中旬展開激烈辯論https://t.co/VIzext6Aaz。"
    }
  ]
}